IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation

• Petra D. Cravens,

  Affiliation Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States of America

  ⨯
• Rehana Z. Hussain,

  Affiliation Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States of America

  ⨯
• William A. Miller-Little,

  Affiliation Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States of America

  ⨯
• Li-Hong Ben,

  Affiliation Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States of America

  ⨯
• Benjamin M. Segal,

  Affiliation Department of Neurology, University of Michigan, Ann Arbor, MI, United States of America

  ⨯
• Emily Herndon,

  Affiliation Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States of America

  ⨯
• Olaf Stüve

  * E-mail: olaf.stuve@utsouthwestern.edu

  Affiliations Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States of America, Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, TX, United States of America, Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany

  ⨯